Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment

Researchers from the University of Chicago and Boston Biomedical Research Institute have described the three-dimensional structure of edema factor, one of the three toxins that make anthrax so deadly. This finding, published in the January 24 issue of Nature, is a crucial step toward designing drugs to block the harmful effects of anthrax and perhaps other bacterial toxins.

Although antibiotics can kill the bacteria, anthrax produces toxins that can cause death even after the bacteria have been eradicated. Since some forms of anthrax infection produce few symptoms until the disease is advanced, physicians need better drugs to counteract these toxins.

"Knowing the structure of edema factor and how it works allows us to design drugs that can block its effects," said Wei-Jen Tang, Ph.D., associate professor in the Ben May Cancer Research Laboratories at the University of Chicago and director of the study.

Anthrax produces three toxins that work together. One, called protective antigen, allows the other two to enter target cells. The second, lethal factor, destroys cells of the immune system. When immune cells die they release inflammatory agents that can cause septic shock, leading to death. The structure for protective antigen was published in February, 1997, and that of lethal factor in November, 2001.

The structure of the third toxin, called edema factor because

Contact: John Easton
University of Chicago Medical Center

Page: 1 2 3 4

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Third set of awards are announced under interagency biodiversity program
3. Large brains not required? Third and smallest skull of first Eurasians reported in Science
4. Rutgers scientists create high-protein corn with Third World potential
5. Third Wave scientists publish advance in gene expression monitoring with revolutionary RNA Invader Assay
6. University Of Kentucky Researcher Awarded MERIT Extension For Study Of Third World Killer
7. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
8. Fortified Drink Improves Third World Nutrition
9. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
10. Building the whole cell from pieces
11. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?

Post Your Comments:

(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
Cached News: